JPS5690063A - Heterocyclic compound active to histamine receptor* its manufacture and its composition - Google Patents

Heterocyclic compound active to histamine receptor* its manufacture and its composition

Info

Publication number
JPS5690063A
JPS5690063A JP13861880A JP13861880A JPS5690063A JP S5690063 A JPS5690063 A JP S5690063A JP 13861880 A JP13861880 A JP 13861880A JP 13861880 A JP13861880 A JP 13861880A JP S5690063 A JPS5690063 A JP S5690063A
Authority
JP
Japan
Prior art keywords
manufacture
composition
heterocyclic compound
histamine receptor
compound active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP13861880A
Other languages
English (en)
Inventor
Buratsudoshiyoo Jiyon
Uiriamu Otsukusufu Arekusandaa
Ian Kaataa Sukoopuz Deibitsudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of JPS5690063A publication Critical patent/JPS5690063A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP13861880A 1979-10-03 1980-10-03 Heterocyclic compound active to histamine receptor* its manufacture and its composition Pending JPS5690063A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7934347 1979-10-03

Publications (1)

Publication Number Publication Date
JPS5690063A true JPS5690063A (en) 1981-07-21

Family

ID=10508267

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13861880A Pending JPS5690063A (en) 1979-10-03 1980-10-03 Heterocyclic compound active to histamine receptor* its manufacture and its composition

Country Status (15)

Country Link
US (1) US4324792A (ja)
JP (1) JPS5690063A (ja)
AU (1) AU6294580A (ja)
BE (1) BE885507A (ja)
DE (1) DE3037313A1 (ja)
DK (1) DK420480A (ja)
ES (3) ES8203855A1 (ja)
FI (1) FI803127L (ja)
FR (1) FR2466461A1 (ja)
GB (1) GB2062626B (ja)
IT (1) IT1144007B (ja)
NL (1) NL8005491A (ja)
NZ (1) NZ195144A (ja)
SE (1) SE8006953L (ja)
ZA (1) ZA806146B (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013537898A (ja) * 2010-09-27 2013-10-07 ビオポロジェ ヒスタミンh4受容体リガンドとしてのベンザゾール誘導体

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT78388B (en) * 1983-04-12 1986-09-15 Smithkline Beckman Corp Dopamine-beta-hydroxylase inhibitors
US4532331A (en) * 1983-04-12 1985-07-30 Smithkline Beckman Corporation 1-Benzyl-2-aminomethyl imidazole derivatives
US4602093A (en) * 1984-02-08 1986-07-22 Merck & Co., Inc. Novel substituted imidazoles, their preparation and use
US4661602A (en) * 1985-03-29 1987-04-28 G. D. Searle & Co. Substituted alkyl imidazole derivatives
NZ238688A (en) * 1990-06-28 1992-05-26 Smithkline Beecham Corp Substituted histidines: pharmaceutical compositions, preparation and uses thereof
US5807872A (en) * 1992-12-16 1998-09-15 Schering Corporation Imidazoylalkyl substituted with a six membered nitrogen containing heterocyclic ring
US5972984A (en) * 1995-06-06 1999-10-26 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
JP2001520222A (ja) * 1997-10-22 2001-10-30 ゼネカ・リミテッド イミダゾール誘導体およびファルネシルタンパク質トランスフェラーゼインヒビターとしてのそれらの使用
WO1999020611A1 (en) 1997-10-22 1999-04-29 Zeneca Limited Imidazole derivatives and their use as farnesyl protein transferase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2532547A (en) * 1950-12-05 Z-aminoalkyl-glyoxaline derivatives
GB1421792A (en) * 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
US4152443A (en) * 1973-07-13 1979-05-01 Smith Kline & French Laboratories Limited Imidazolyl thioureas, ureas and guanidines
US4006137A (en) * 1975-08-21 1977-02-01 E. R. Squibb & Sons, Inc. 2-Ethenyl imidazolium derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013537898A (ja) * 2010-09-27 2013-10-07 ビオポロジェ ヒスタミンh4受容体リガンドとしてのベンザゾール誘導体

Also Published As

Publication number Publication date
ES495589A0 (es) 1981-12-16
NZ195144A (en) 1983-02-15
ES8205204A1 (es) 1982-06-01
FI803127L (fi) 1981-04-04
FR2466461B1 (ja) 1983-05-20
ES505556A0 (es) 1982-12-01
BE885507A (fr) 1981-04-02
IT8049815A0 (it) 1980-10-03
DE3037313A1 (de) 1981-04-23
GB2062626B (en) 1983-10-05
ZA806146B (en) 1982-01-27
SE8006953L (sv) 1981-04-04
GB2062626A (en) 1981-05-28
FR2466461A1 (fr) 1981-04-10
ES8203855A1 (es) 1981-12-16
DK420480A (da) 1981-04-04
NL8005491A (nl) 1981-04-07
US4324792A (en) 1982-04-13
ES505555A0 (es) 1982-06-01
ES8301221A1 (es) 1982-12-01
AU6294580A (en) 1981-04-16
IT1144007B (it) 1986-10-29

Similar Documents

Publication Publication Date Title
JPS5562063A (en) Heterocyclic compounds*their manufacture and medical composition containing them
IL58579A0 (en) Nitrogen heterocyclic compounds their preparation and pharmaceutical compositions containing them
PH15980A (en) 2-imidazoline derivatives and pharmaceutical composition
GB2011368B (en) Furface active composition
JPS5484575A (en) Imidazoline compound*its manufacture and insecticide composition
PH14555A (en) Alkoxypyridyl compound derivatives and pharmaceutical composition useful as histamine h2 antagonists
JPS53141273A (en) Novel azolylether derivative *its production and fungicidal composition containing same as active component
JPS5690063A (en) Heterocyclic compound active to histamine receptor* its manufacture and its composition
JPS565465A (en) Benzimidazole derivative* its manufacture and medicinal composition of same as active component
JPS559074A (en) Compound and drug composition
IL58681A0 (en) Heterocyclic compounds their preparation and pharmaceutical compositions containing them
JPS54138530A (en) Dilignol and dilignol analogur compound as hepatitis therapeutically active substance
JPS5513290A (en) Heterocyclic compound
JPS568359A (en) Manufacture of heterocyclic compound
JPS55108869A (en) Substituted 22iminoo1*33dithio and 1*33oxathio heterocyclic compound
ZA794209B (en) Pharmaceutically active heterocyclic compounds
JPS5576885A (en) Heterocyclic compound and its manufacture
JPS5531070A (en) Heterocyclic compound
JPS554371A (en) Heterocyclic compound
JPS52142062A (en) Novel compound having pharmacological activity* its preparation* intermediate compound for its preparation and medical composition containing novel compound
JPS55162776A (en) Novel hydantoin derivative* its manufacture and its use
JPS5646553A (en) Inputtstage to chargeetransferrdevice of monolithic integration
PH15713A (en) Benzimidazole derivatives and compositions containing same
JPS53116377A (en) Novel compound and biologically active composition
NZ190548A (en) Preparation of the crystalline methanolate form of sodium cefamandole